Evidence map›Paper›PMID 37497076›Full record

ReviewFrontiers in allergy2023

Application of AllerCatPro 2.0 for protein safety assessments of consumer products.

Nora L Krutz, Ian Kimber, Jason Winget, Minh N Nguyen, Vachiranee Limviphuvadh, Sebastian Maurer-Stroh, Catherine Mahony, G Frank Gerberick

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in allergy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 4 countries.

Nora L KrutzNV Procter & Gamble Services Company SA, Global Product Stewardship, Strombeek-Bever, Belgium.
Ian KimberFaculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Jason WingetThe Procter & Gamble Company, Mason, OH, United States.
Minh N NguyenBioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Vachiranee LimviphuvadhBioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Sebastian Maurer-StrohBioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Catherine MahonyProcter & Gamble, Global Product Stewardship, Reading, United Kingdom.
G Frank GerberickGF3 Consultancy LLC, West Chester, OH, United States.
Agency for Science, Technology and Research · SGBioinformatics Institute · SGNational University of Singapore · SGProcter & Gamble (Belgium) · BEProcter & Gamble (United Kingdom) · GBProcter & Gamble (United States) · USUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Foreign proteins are potentially immunogenic, and a proportion of these are able to induce immune responses that result in allergic sensitization. Subsequent exposure of sensitized subjects to the inducing protein can provoke a variety of allergic reactions that may be severe, or even fatal. It has therefore been recognized for some time that it is important to determine

Indexed as

bioinformaticsbotanicalsIgE antibodyin siliconatural substancesprotein allergenicityrisk assessment

Identifiers

PMID37497076
PMCPMC10367106
OpenAlexW4383888105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.